{
    "clinical_study": {
        "@rank": "72324", 
        "arm_group": [
            {
                "arm_group_label": "Group TN", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Tranexamic acid and sodium chloride injection at 10mg/kg, IV (in the vein) for 30min, before incision.Then at 1mg/kg/h, IV pump, until the surgery is over.\nNormal saline (NS) 100ml IV for 20min, before incision."
            }, 
            {
                "arm_group_label": "Group TD", 
                "arm_group_type": "Experimental", 
                "description": "Tranexamic acid and sodium chloride injection at 10mg/kg, IV (in the vein) for 30min,before incision.Then at 1mg/kg/h,IV pump,until the surgery is over.\nDesmopressin acetate injection at 0.3\u03bcg/kg dissolved in 100ml NS, IV for 20min, before incision."
            }
        ], 
        "brief_summary": {
            "textblock": "Intraoperative administration of tranexamic acid (TXA,T) reduces significantly blood loss\n      and blood transfusion requirements during spinal posterior fusion in adolescents with\n      scoliosis. TXA acts mainly by inhibit the  plasminogen activator.\n\n      Desmopressin (DDAVP ,D) can inhibit the fibrinolytic activity  by inducing the release of\n      von Willebrand factor from the endothelial cells. But at the same time, it releases\n      tissue-type plasminogen activator (t-PA), which may cripple its hemostatic effect.\n\n      The investigators supposed that if the investigators combine TXA with DDAVP in scoliosis\n      correction surgery, the blood loss and the transfusion need would be reduced  significantly."
        }, 
        "brief_title": "Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Idiopathic Scoliosis", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Scoliosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Intraoperative administration of tranexamic acid (TXA,T) reduces significantly blood loss\n      and blood transfusion requirements during spinal posterior fusion in adolescents with\n      scoliosis. TXA acts mainly by inhibit the  plasminogen activator. Desmopressin (DDAVP ,D)\n      can inhibit the fibrinolytic activity  by inducing the release of von Willebrand factor from\n      the endothelial cells. But at the same time, it releases tissue-type plasminogen activator\n      (t-PA), which may cripple its hemostatic effect.\n\n      The investigators designed a a randomized double-blind clinical combining TXA with DDAVP in\n      scoliosis correction surgery to observe if the blood loss and the transfusion need would be\n      reduced or not."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  idiopathic scoliosis patients undergoing posterior scoliosis correction surgery\n\n          -  American society of anesthesiologists(ASA) classification:\u2160-\u2161\n\n          -  patients who agreed to participate in this study and has signed the informed consent\n\n        Exclusion Criteria:\n\n          -  blood disease\uff0csuch as anaemia, idiopathic thrombocytopenic purpura(ITP)\n\n          -  history of bleeding or ecchymosis\n\n          -  disorders of laboratory examination on platelets(PLT),prothrombin time(PT),activated\n             partial thromboplastin Time(aPTT),Fibrinogen,D-dimers\n\n          -  hypertension\n\n          -  cardiac disease,such as unstable angina, myocardial infarction in recent sis months,\n             cardiac disfunction, congenital heart disease, pulmonary heart disease\n\n          -  cerebral ischemia\n\n          -  administering with  anticoagulants or nonsteroidal anti-inflammatory drug(NSAID)\n\n          -  hepatic or renal disease or disfunction\n\n          -  blood transfusion in recent one month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02084342", 
            "org_study_id": "TDS-SYSU-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group TN", 
                    "Group TD"
                ], 
                "description": "10mg/kg, IV (in the vein) for 30min, before incision. then at 1mg/kg/h, IV pump, until the surgery is over.", 
                "intervention_name": "tranexamic acid and sodium chloride injection", 
                "intervention_type": "Drug", 
                "other_name": "TXA"
            }, 
            {
                "arm_group_label": "Group TN", 
                "description": "100ml, IV for 30min,before incision.", 
                "intervention_name": "normal saline", 
                "intervention_type": "Drug", 
                "other_name": "NS"
            }, 
            {
                "arm_group_label": "Group TD", 
                "description": "0.3\u03bcg/kg dissolved in 100ml NS\uff0cIV for 30min\uff0cbefore incision.", 
                "intervention_name": "desmopressin acetate injection", 
                "intervention_type": "Drug", 
                "other_name": "DDAVP"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Deamino Arginine Vasopressin", 
                "Tranexamic Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "desmopressin", 
            "tranexamic acid", 
            "blood loss", 
            "transfusion need", 
            "posterior scoliosis orthopedics"
        ], 
        "lastchanged_date": "March 10, 2014", 
        "number_of_arms": "2", 
        "official_title": "Efficacy and Safety of Desmopressin Combined With Tranexamic Acid on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery", 
        "other_outcome": {
            "measure": "postoperative complications", 
            "safety_issue": "Yes", 
            "time_frame": "up to 24 weeks after the surgery"
        }, 
        "overall_official": {
            "affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "last_name": "Wenqi Huang, Ph.D, M.D.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The blood loss include the volume of blood in suction bottles, the weight of sponges and seroma volume of drainage 3 days after surgery. All fluids added to the surgical field intraoperatively were carefully quantified and deducted from the measured blood loss.", 
            "measure": "blood loss", 
            "safety_issue": "Yes", 
            "time_frame": "during and 3 days after the surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02084342"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "investigator_full_name": "Liu Weifeng", 
            "investigator_title": "attending doctor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "The blood transfusion includes all the product needed during and in 3 days after the surgery.", 
            "measure": "blood transfusion", 
            "safety_issue": "No", 
            "time_frame": "during and 3 days after the surgery"
        }, 
        "source": "First Affiliated Hospital, Sun Yat-Sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Liu Weifeng", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}